Clinical Trial Update: Transoral Incisionless Fundoplication (TIF) for Laryngopharyngeal Reflux (LPR) Patients

View source ↗

Summary

The clinical trial evaluating Transoral Incisionless Fundoplication (TIF) for laryngopharyngeal reflux and GERD has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Laryngopharyngeal Reflux

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Gastroesophageal Reflux Disease (GERD), Laryngopharyngeal Reflux (LPR) | Status: WITHDRAWN